Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Diagnos Laboratorium Utama PT Tbk (DGNS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
334 +4    +1.21%
05:14:11 - Closed. Currency in IDR ( Disclaimer )
Type:  Equity
Market:  Indonesia
ISIN:  ID1000158702 
  • Volume: 10,283,000
  • Bid/Ask: 330 / 334
  • Day's Range: 328 - 354
Diagnos Laboratorium Utama PT Tbk 334 +4 +1.21%

DGNS Balance Sheet

 
Featured here, the Balance Sheet for Diagnos Laboratorium Utama PT Tbk, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 87805.45 97337.53 95666.13 102919.71
Cash and Short Term Investments 11940.79 22237.97 15765.1 24605.91
Cash - - - -
Cash & Equivalents 10244.91 19695.36 13222.49 22063.3
Short Term Investments 1695.88 2542.61 2542.61 2542.61
Total Receivables, Net 45252.37 40491.61 42089.1 42535.01
Accounts Receivables - Trade, Net 38280.33 33499.42 35055.78 35502.59
Total Inventory 5141.95 4858.79 6347.68 6437.3
Prepaid Expenses 194.89 324.01 344.39 233.42
Other Current Assets, Total 25275.46 29425.15 31119.85 29108.07
Total Assets 271475.14 253679.63 242455.09 245943.5
Property/Plant/Equipment, Total - Net 164248.3 139416.11 129918.87 126381.33
Property/Plant/Equipment, Total - Gross 194348.66 173838.91 160721.97 153546.46
Accumulated Depreciation, Total -30100.36 -34422.8 -30803.1 -27165.12
Goodwill, Net - - - -
Intangibles, Net 720.43 783.88 805.44 643.28
Long Term Investments 12950.5 12950.5 12950.5 12950.5
Note Receivable - Long Term 6972.04 6992.19 7033.32 7032.43
Other Long Term Assets, Total 4718.97 2008.33 2033.33 2058.33
Other Assets, Total -12107.59 -2481.78 -998.14 -3456.69
Total Current Liabilities 14444.21 11026.65 13656.65 12934.52
Accounts Payable 6089.97 4180.58 4536.92 3079.1
Payable/Accrued - - - -
Accrued Expenses 3178.44 1697.86 1196.19 765.21
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 3709.67 3321.33 5616.54 3765.47
Other Current liabilities, Total 1466.13 1826.88 2307.01 5324.75
Total Liabilities 75884.72 53902.17 39765.34 38980.58
Total Long Term Debt 51004.33 32950.91 16735.02 16732.45
Long Term Debt 30000 30000 15149.68 13749.76
Capital Lease Obligations 21004.33 2950.91 1585.34 2982.69
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 10436.18 9924.61 9373.68 9313.61
Total Equity 195590.42 199777.45 202689.75 206962.92
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 31250 31250 31250 31250
Additional Paid-In Capital 36706.72 36706.72 36706.72 36706.72
Retained Earnings (Accumulated Deficit) 131517.64 134522.73 137435.02 141708.19
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -3883.95 -2701.99 -2701.99 -2701.99
Total Liabilities & Shareholders' Equity 271475.14 253679.63 242455.09 245943.5
Total Common Shares Outstanding 1250 1250 1250 1250
Total Preferred Shares Outstanding - - - -
* In Millions of IDR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DGNS Comments

Write your thoughts about Diagnos Laboratorium Utama PT Tbk
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Abin Nidhom
Abin Nidhom Aug 11, 2022 5:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great for long term investment
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email